期刊文献+

定量动态增强磁共振评估乳腺癌新辅助化疗疗效的应用研究 被引量:29

Role of the dynamic contrast-enhanced MRI in assessing the response to neoadjuvant chemotherapy of breast cancer
在线阅读 下载PDF
导出
摘要 背景与目的:乳腺癌的新辅助化疗(neoadjuvant chemotherapy,NAC)已成为成熟的治疗方法,但疗效评估尚未有统一有效的方法。该研究即探讨定量动态增强磁共振在乳腺癌NAC疗效评估中的价值。方法:24例术前行NAC的乳腺癌确诊患者(24例均为浸润性导管癌),分别于NAC前、第2个疗程后、化疗结束但术前3个时间点行定量动态增强磁共振检查,分析NAC前后肿瘤最长径及动态增强磁共振定量参数:容量转移常数(K^(trans))、速率常数(K_(ep))、血管外细胞外间隙容积比(V_e)的变化。结果:24例患者均为单侧单发乳腺癌病灶,以RECIST标准分为有效组(17个)和无效组(7个),有效组与无效组K^(trans)、K_(ep)在NAC前与第2个疗程、化疗前与化疗结束差异均有统计学意义(P<0.05),V_e在有效组与无效组治疗前后差异均无统计学意义(P>0.05)。结论:定量动态增强磁共振可用来评估NAC疗效,并且K^(trans)、K_(ep)可做到定量,使评估结果更为客观真实,但V_e对判断治疗效果未见明显优势。 Background and purpose: Neoadjuvant chemotherapy to breast cancer has become a mature treat- ment method. The purpose of this study was to evaluate the dynamic contrast-enhanced MRI in assessing the response to neoadjuvant chemotherapy (NAC). Methods: Twenty-four female patients with breast carcinoma (24 were all inva- sive ductal carcinoma) underwent dynamic contrast-enhanced MRI (DCE-MRI) before, after the second and final cycle of NAC. For each patient and each MRI examination, the maximum diameter of tumor, volume transfer constant (Ktrans), exchange rate constant (Kep), and extravascular extracellular volume fraction (V0) were compared. According to the method of response evaluation criteria in solid tumor (RECIST), the results of neoadjuvant chemotherapy were divided into responder and non-responder. Results: All 24 patients were unilateral and single breast cancer; there were 17 cases of responders and 7 cases of non-responders according to RECIST criteria. For 17 cases of responders, both the average values of Ktrans and Kop were significantly descended after neoadjuvant chemotherapy (all P〈0.05). Conclusion: The quantitative parameters of Ktrans and Kep can evaluate objectively and veridically the response to neoadjuvant chemother- apy for breast cancer in dynamic contrast-enhanced MRI.
出处 《中国癌症杂志》 CAS CSCD 北大核心 2016年第7期623-628,共6页 China Oncology
关键词 乳腺癌 新辅助化疗 疗效评估 磁共振成像 定量动态增强磁共振检查 Breast neoplasms Neoadjuvant chemotherapy Respanse evaluation Magnetic resonance imaging Quantitative dynamic contrast-enhanced MRI
作者简介 通信作者:顾雅佳E—mail:cjr.guyajia@vip.163.com
  • 相关文献

参考文献10

二级参考文献42

  • 1张嵘,李勇,任俊杰,梁碧玲,文艳玲,李海刚.乳腺叶状瘤的影像诊断[J].中华放射学杂志,2004,38(7):717-720. 被引量:23
  • 2Sinha S,Sinha U.Recent advances in breast MRI and MRS.NMB Biomed,2009,22:3-16.
  • 3Murase K.Efficient method for calculating kinetic parameters using T1-weighted dynamic contrast-enhanced magnetic resonance imaging.Magn Reson Med,2004,51:858-862.
  • 4Yankeelov TE,Lepage M,Chakravarthy A,et al.Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer:initial results.Magn Reson Imaging,2007,25:1-13.
  • 5Tofts PS,Brix G,Buckley DL,et al.Estimating kinetic parameters from dynamic contrast-enhanced T1 -weighted MRI of a diffusable tracer:standardized quantities and symbols.J Magn Rein Imaging,1999,10:223-232.
  • 6Tavassoli FA,Devillee P.WHO classification of tumours pathology & genetics:tumours of the breast and female genital organs.Lyon:IARC Press,2003:9-112.
  • 7Huang W,Li X,Morris EA,et al.The magnetic resonance shutter speed discriminates vascular properties of malignant and benign breast tumors in vivo.Proc Natl Acad Sci USA,2008,105:17943-17948.
  • 8Barrett T,Brechbiel M,Bernardo M,et aL MRI of tumor angiogenesis.J Magn Reson Imaging,2007,26:235-249.
  • 9Toffs PS.Modeling tracer kinetics in dynamic Gd-DTPA MR imaging J Magn Reson Imaging,1997,7:91-101.
  • 10Wang Y,Huang W,Panicek DM.Feasibility of using limitedpopulation-based arterial input function for pharmacokinetic modeling of osteosarcoma dynamic contrast-enhanced MRI data.Magn Reson Med,2008,59:1183-1189.

共引文献1322

同被引文献192

引证文献29

二级引证文献166

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部